HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025)
HUTCHMED (China) (HCM) reported Non-Current Deffered Revenue of $20.1 million for Q4 2025, down 34.6% quarter-over-quarter from $30.8 million in Q2 2025.
HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 10 years of Non-Current Deffered Revenue data on file, last reported at $20.1 million in Q4 2025.
- Non-Current Deffered Revenue for Q4 2025 came in at $20.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $20.1 million (changed N/A YoY), and the FY2025 annual result was $20.1 million, changed N/A from the prior year.
- Non-Current Deffered Revenue fell to $20.1 million in Q4 2025 per HCM's latest filing, from $30.8 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $97.2 million in Q2 2023 and troughed at $190000.0 in Q4 2022.
- A 4-year average of $41.8 million and a median of $30.8 million in 2025 frame the typical range for Non-Current Deffered Revenue.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue slumped 37.61% in 2024, then plunged 49.22% in 2025.
- A 4-year view of Non-Current Deffered Revenue shows it stood at $190000.0 in 2022, then soared by 51045.26% to $97.2 million in 2023, then slumped by 37.61% to $60.6 million in 2024, then plunged by 66.79% to $20.1 million in 2025.
- Business Quant data shows HCM's Non-Current Deffered Revenue at $20.1 million in Q4 2025, $30.8 million in Q2 2025, and $60.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - | 20.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.13 Mn |
| Jun 30, 2025 | 30.79 Mn |
| Jun 30, 2024 | 60.63 Mn |
| Jun 30, 2023 | 97.18 Mn |
| Dec 31, 2022 | 190,000.00 |
| Dec 31, 2020 | 484,000.00 |
| Dec 31, 2019 | 133,000.00 |
| Jun 30, 2019 | 7.51 Mn |
| Mar 31, 2019 | 1.39 Mn |
| Dec 31, 2018 | 408,000.00 |
| Dec 31, 2017 | 1.99 Mn |
| Dec 31, 2016 | 2.26 Mn |
| Dec 31, 2015 | 2.13 Mn |